MoonLake Immunotherapeutics Current Assets

MoonLake Immunotherapeutics (MLTX) currently reports a current assets of $400M as of March 2026. That compares with $510M in the prior-year period — down 21.7% year over year. Use the charts on this page to explore MoonLake Immunotherapeutics's current assets history and peer comparisons.

MoonLake Immunotherapeutics's current assets decreased from $510M to $400M — a 21.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MoonLake Immunotherapeutics reported $400M in current assets as of March 2026. That compares with $510M in the prior-year period — down 21.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $400M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MoonLake Immunotherapeutics, and consider following MLTX for alerts when major investors trade the stock.